The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting. A team used an interpretive description approach to evaluate the self-management support intervention. The study investigators say the 5-year survival rate "dramatically exceeds historical standards." The personalized, stratified follow-up pathway is led by advanced nurse practitioners and general practitioners. Learn what a team found when they implemented a pre-appointment electronic PRO measure for patients with prostate cancer. A collaborative approach between nurses and caregivers may help improve quality of life in patients and caregivers. The combination was evaluated in the phase II KEYNOTE-199 clinical trial, which included multiple cohorts. The survey of oncology nurses identified 3 top areas of unmet needs of patients with GU cancers. Learn how a team developed an online group cognitive rehabilitation program for survivors of prostate cancer. The trial is the first to evaluate the combination of an ADC and a TKI in metastatic urothelial carcinoma. Learn about a pilot study of a survivorship program that is currently enrolling men with advanced GU cancers. The study showed that a certain starting dose of the ADC maximized the likelihood of response to treatment. A new study evaluated how social determinants of health can affect the risk of death in patients with cancer. Learn how a team implemented a nursing intervention based on the gratitude extension-construction theory. EV-302/KEYNOTE-A39 investigators say these results support the combination as a new standard of care for certain patients. A new study shows why it's critical to prioritize clear communication and patient participation in treatment planning. More than 20% of patients in the study had 10 or more drug prescriptions, indicating a need for careful management. The Omaha system is a standardized tool for nursing practice, documentation, and information management. Researchers evaluated the treatment in a large cohort of patients from the GUARDIANS consortium. Amy Marbaugh, RN, BSN, MS, of the Kidney Cancer Association, explains why it's critical to raise awareness.